Indices to measure risk of HIV acquisition in Rakai, Uganda

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Kagaayi, Joseph ^a,b   Gray, Ronald H ^c   Whalen, Christopher ^e   Fu, Pingfu ^b   Neuhauser, Duncan ^b   McGrath, Janet W ^d   Sewankambo, Nelson K ^f   Serwadda, David ^f   Kigozi, Godfrey ^b   Nalugoda, Fred ^b   Reynolds, Steven J ^g,h   Wawer, Maria J ^c   Singer, Mendel E ^b  

^a RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

^f MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; CIRCUMCISION; COMMUNITY; CONCURRENT SEXUAL PARTNERSHIP; EDUCATION; FEMALE; GENITAL ULCER; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OCCUPATION; SEXUAL BEHAVIOR; UGANDA; COHORT ANALYSIS; HEALTH STATUS INDICATOR; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HEALTH STATUS INDICATORS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SEXUAL BEHAVIOR; UGANDA; YOUNG ADULT;

EID: 84899437921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092015     Document Type: Article

References (41)

1. Bautista-Arredondo S, Gadsden P, Harris JE, Bertozzi SM (2008) Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework. AIDS 22 Suppl 1: S67-74.
2. Herida M, Larsen C, Lot F, Laporte A, Desenclos JC, et al. (2006) Cost-effectiveness of HIV post-exposure prophylaxis in France. AIDS 20: 1753-1761. (Pubitemid 44299367)
3. Hughes D, Morris S (1996) The cost-effectiveness of condoms in the prevention of HIV infection in England and Wales: should condoms be available on prescription? J Health Serv Res Policy 1: 205-211.
4. Juusola JL, Brandeau ML, Owens DK, Bendavid E (2012) The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with men. Ann Intern Med 156: 541-550.
5. Kahn JG (1996) The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? Am J Public Health 86: 1709-1712.
6. Long EF, Brandeau ML, Owens DK (2010) The cost-effectiveness and population outcomes of expanded HIV screening and antiretroviral treatment in the United States. Ann Intern Med 153: 778-789.
7. Youngkong S, Teerawattananon Y, Tantivess S, Baltussen R (2012) Multicriteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand. Health Res Policy Syst 10: 6.
8. Weiss HA, Quigley MA, Hayes RJ (2000) Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS 14: 2361-2370.
9. Gray RH, Kiwanuka N, Quinn TC, Sewankambo NK, Serwadda D, et al. (2000) Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 14: 2371-2381.
10. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657-666.
11. Abbas UL, Anderson RM, Mellors JW (2007) Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings. PLoS One 2: e875.
12. Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, et al. (2013) The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS 27: 447-458.
13. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P, Group CHDRP (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286: 180-187. (Pubitemid 32640849)
14. Steyerberg EW, Roobol MJ, Kattan MW, van der Kwast TH, de Koning HJ, et al. (2007) Prediction of indolent prostate cancer: validation and updating of a prognostic nomogram. J Urol 177: 107-112; discussion 112.
15. Kahle EM, Hughes JP, Lingappa JR, John-Stewart G, Celum C, et al. (2012) An empiric risk scoring tool for identifying high-risk heterosexual HIV-1 serodiscordant couples for targeted HIV-1 prevention. J Acquir Immune Defic Syndr.
16. Fox J, White PJ, Weber J, Garnett GP, Ward H, et al. (2011) Quantifying sexual exposure to HIV within an HIV-serodiscordant relationship: development of an algorithm. AIDS 25: 1065-1082.
17. Gray R, Ssempiija V, Shelton J, Serwadda D, Nalugoda F, et al. (2011) The contribution of HIV-discordant relationships to new HIV infections in Rakai, Uganda. AIDS 25: 863-865.
18. Chemaitelly H, Shelton JD, Hallett TB, Abu-Raddad LJ (2013) Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub- Saharan Africa. AIDS 27: 251-260.
19. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Paxton L, et al. (1998) A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 12: 1211-1225. (Pubitemid 28302424)
20. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, et al. (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 353: 525-535. (Pubitemid 29078422)
21. Arora P, Nagelkerke NJ, Jha P (2012) A systematic review and meta-analysis of risk factors for sexual transmission of HIV in India. PLoS One 7: e44094.
22. Kelly RJ, Gray RH, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. (2003) Age differences in sexual partners and risk of HIV-1 infection in rural Uganda. J Acquir Immune Defic Syndr 32: 446-451. (Pubitemid 36363160)
23. Wojcicki JM (2005) Socioeconomic status as a risk factor for HIV infection in women in East, Central and Southern Africa: a systematic review. J Biosoc Sci 37: 1-36.
24. Koenig MA, Lutalo T, Zhao F, Nalugoda F, Kiwanuka N, et al. (2004) Coercive sex in rural Uganda: prevalence and associated risk factors. Soc Sci Med 58: 787-798. (Pubitemid 37524001)
25. Zablotska IB, Gray RH, Koenig MA, Serwadda D, Nalugoda F, et al. (2009) Alcohol use, intimate partner violence, sexual coercion and HIV among women aged 15-24 in Rakai, Uganda. AIDS Behav 13: 225-233.
26. Zablotska IB, Gray RH, Serwadda D, Nalugoda F, Kigozi G, et al. (2006) Alcohol use before sex and HIV acquisition: a longitudinal study in Rakai, Uganda. AIDS 20: 1191-1196. (Pubitemid 43786108)
27. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. (2005) Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2: e298.
28. Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369: 643-656. (Pubitemid 46281312)
29. Denison JA, O'Reilly KR, Schmid GP, Kennedy CE, Sweat MD (2008) HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990-2005. AIDS Behav 12: 363-373.
30. Matovu JK, Gray RH, Makumbi F, Wawer MJ, Serwadda D, et al. (2005) Voluntary HIV counseling and testing acceptance, sexual risk behavior and HIV incidence in Rakai, Uganda. AIDS 19: 503-511. (Pubitemid 40515854)
31. Commission UNA (2009) Uganda HIV Modes of Transmission and Prevention Response Analysis.
32. Harrell F aregImpute. Available: http://cran.r-project.org/web/packages/ Hmisc. Accessed 2013 Mar 25.
33. Therneau PGT (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81: 515-526.
34. Atkinson AC (1980) A note on the generalized infromation criterion for choice of a model. Biometrika 67: 413-418.
35. Van Houwelingen JC, Le Cessie S (1990) Predictive value of statistical models. Stat Med 9: 1303-1325. (Pubitemid 20361741)
36. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15: 361-387. (Pubitemid 26072233)
37. Harrell F Regression modelling strategies. Available:http://cran.r- project.org/web/packages/rms/rms.pdf. Accessed 2013 Mar 25.
38. Santelli JS, Edelstein ZR, Mathur S, Wei Y, Zhang W, et al. (2013) Behavioral, Biological, and Demographic Risk and Protective Factors for New HIV Infections Among Youth in Rakai, Uganda. J Acquir Immune Defic Syndr 63: 393-400.
39. Steyerberg EW (2010) Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. 233 Spring Street, New York,NY 10013, USA: Springer Science+Business Media.
40. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, et al. (2012) Preexposure prophylaxis for HIV infection among African women. N Engl J Med 367: 411-422.
41. Marrazzo J RG, Nair G (2013) Pre-exposure prophylaxis for HIV in women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE (MTN 003). 20th Conference on Retroviruses and Opportunistic Infections. Atlanta,GA.